- Buy Plant Medicine
- MEN'S FORMULAS
- Intestinal Health, Digestion, Weight Management, Triphala: 96 capsules
Intestinal Health, Digestion, Weight Management, Triphala: 96 capsules
Free shipping in the continental US. We are not shipping out of the country at this time.
Organic Triphala is recommended and used more than any other Ayurvedic herbal formulation. Triphala is most commonly known for its use as a gentle bowel tonic, helpful in digestion and supporting regular bowel movements. One ingredient, Haritaki, is considered not safe during pregnancy. Therefore do not take this while pregnant. Triphala has also been shown to be a powerful antioxidant, protecting cells from the damaging effects of free radicals. The three fruits involved in making Triphala are also known for their individual effects to support lungs, urinary tract and for a clear complexion. 1/2 tsp. a day is the recommended dosage if using the powder (churna). It is fairly bitter to taste--which is part of the healing. Mix with a little warm water, let it sit for a few minutes and drink. You can also buy it here in capsules.
Translated as "three fruits", it is composed of the dried fruits of amalaki, bibhitaki and haritaki. Triphala readily removes excess vata, pitta and kapha from the body, bringing balance and proper functioning to the system. It is commonly taken as a daily supplement to help maintain balance of the doshas. Use daily for rejuvenation and weight loss.
Do not take during pregnancy.
Benefits of Triphala
Assists natural internal cleansing
- Gently maintains regularity
- Nourishes and rejuvenates the tissues
- Supports healthy digestion and absorption
- Natural antioxidant
Memorial Sloan Kettering Cancer Center has these recommendations about using Triphala https://www.mskcc.org/cancer-care/integrative-medicine/herbs/triphala
This study published in PubMed, validates the traditional Ayurvedic use of Triphala http://www.ncbi.nlm.nih.gov/pubmed/23239004.
"Indian scientists have claimed for years that Triphala has value as a detoxifying and anti-cancer agent. Now researchers at the University of Pittsburgh Cancer Institute say they have shown that it can prevent or slow the growth of pancreatic cancer tumours implanted in mice.
The latest findings, presented to the annual meeting of the American Association of Cancer Research in Los Angeles, suggest some herbal preparations may have genuine anti-cancer action.
Triphala (Sanskrit tri = three and phala = fruits), composed of the three medicinal fruits Phyllanthus emblica L. or Emblica officinalis Gaertn., Terminalia chebula Retz., and Terminalia belerica Retz. is an important herbal preparation in the traditional Indian system of medicine, Ayurveda. Triphala is an antioxidant-rich herbal formulation and possesses diverse beneficial properties. It is a widely prescribed Ayurvedic herbal formula and is used as a colon cleanser, digestive, diuretic, and laxative. Cancer is a major cause of death, and globally studies are being conducted to prevent cancer or to develop effective nontoxic therapeutic agents. Experimental studies in the past decade have shown that Triphala is useful in the prevention of cancer and that it also possesses antineoplastic, radioprotective and chemoprotective effects.
Network pharmacology analysis suggested that Triphala could comprehensively intervene in proliferation and apoptosis through diverse signaling pathways, mainly including MAPK/ERK, PI3K/Akt/mTOR, and NF-κB/p53. The Cell Counting Kit 8 (CCK-8) assay illustrated that Triphala was able to inhibit cell proliferation with half inhibition concentration (IC50) values of 98.28 ± 13.71, 95.56 ± 8.94, and 101.23 ± 7.76 µg/mL against SK-OV-3, HeLa, and HEC-1-B cells, respectively. The ELISA experiment demonstrated that Triphala was capable of promoting programmed cell death, with dosage correlations. The antiproliferative and proapoptotic activities were confirmed by flow cytometric analysis using Ki67 antibody and Annexin V/propidium iodide (PI) dual staining. Western blotting revealed a decrease in expression levels of phospho-Akt, phospho-p44/42, and phospho-NF-κB p56 in cells administered Triphala, which indicated that the possible mechanism could involve downregulation of MAPK/ERK, PI3K/Akt/mTOR, and NF-κB/p53 signaling pathways, as was predicted. Conclusion. Triphala holds great promise for treating gynecological cancers.
"The products and statements made about specific products on this web site have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this web site or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. You should not use the information on this web site for diagnosis or treatment of any health problem. Always consult with a healthcare professional before starting any new vitamins, supplements, diet, or exercise program, before taking any medication, or if you have or suspect you might have a health problem. Any testimonials on this web site are based on individual results and do not constitute a guarantee that you will achieve the same results."